Pharmacist's Letter Canada | Convenient Monthly Updates + CE

Current Issue

August 2025 Issue

Consider Pros and Cons of Tirzepatide for Obesity

Tirzepatide (Zepbound) will be a new option for obesity...

Resources

Chart: Comparison of Weight Loss Products
Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart

Stay Abreast With the Latest Hypertension Guidance

You play a pivotal role in the detection, treatment, and monitoring of hypertension...

Clarify the Role of Aspirin for Disease Prevention

Up to 1 in 5 patients may still be taking a daily dose of aspirin for primary CV prevention even though it’s no longer recommended for them...

Keep Potential Eye Risks With GLP-1 Agonists in Sight

You’ll see concerns about eye problems with GLP-1 agonists (semaglutide, etc)...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Navigating HIV Care: Prevention, Treatment, and Management

CE-IN-THE-LETTER: Pharmacist's Letter Canada August 2025

LIVE CE: Pharmacy Essential Updates August 2025

PODCAST CE: Medication Talk - HIV Prevention: A Guide to PrEP and PEP

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Group Purchases & Pricing

Pharmacist’s Letter Canada is eligible for bulk discounts. Easily manage staff access and customize CE & training assignments. Bundle with other products for significant savings. Request information